Neurobehavioral burden of multiple sclerosis with nanotheranostics
Bhasker Sriramoju, Rupinder K Kanwar, Jagat R Kanwar Nanomedicine-Laboratory of Immunology and Molecular Biomedical Research (NLIMBR), School of Medicine, Molecular and Medical Research, Faculty of Health, Deakin University, VIC, Australia Abstract: Multiple sclerosis (MS) is a chronic demyelinati...
Saved in:
Main Authors: | Sriramoju B, Kanwar RK, Kanwar JR |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2015
|
Subjects: | |
Online Access: | https://doaj.org/article/8061bea6a1dd4d9f9fd5bc99ab872cf6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative efficacy of alemtuzumab and established treatment in the management of multiple sclerosis
by: Babij R, et al.
Published: (2015) -
Association between smoking and cognitive impairment in multiple sclerosis
by: Özcan ME, et al.
Published: (2014) -
Cognitive dysfunction in pediatric multiple sclerosis
by: Suppiej A, et al.
Published: (2014) -
The Multiple Sclerosis Treatment Optimization Program
by: Annette Langer‐Gould, et al.
Published: (2021) -
Role of oral teriflunomide in the management of multiple sclerosis
by: Tanasescu R, et al.
Published: (2013)